Výsledky vyhledávání - "Bert G. Blijenberg"

Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee

Autor: Hans Lilja, Bert G. Blijenberg, Ulf-Håkan Stenman, H Neels

Publikováno v: BJU international
BJU International, 92(2), 66-70. Wiley-Blackwell Publishing Ltd

OBJECTIVE: To assess the application of a quality control scheme for total prostate-specific antigen (PSA) as used for participants of the European Randomized Study for Screening of Prostate Cancer (ERSPC) during 1996-2002. METHODS: From 1996, the fi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b826b054bc0f9c3f0433ae69b89a4825
https://ora.ox.ac.uk/objects/uuid:7e13d7cb-0941-4807-8773-923104ab0d30

Zobrazit plný text záznamu

On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer

Autor: Ulf-Håkan Stenman, Ron H.N. van Schaik, Hans Lilja, Bert G. Blijenberg, Monique J. Roobol, Chris H. Bangma

Publikováno v: European Journal of Cancer, 46(17), 3109-3119. Elsevier Ltd.

Prostate-specific antigen (PSA) has been the main drive for early detection of prostate cancer (PCa), including in population-based screening as in the European Randomised Study for Screening of Prostate Cancer (ERSPC). The specificity of PSA to indi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d69e51565d2aab8ab3bd754a0fa69f0c
https://doi.org/10.1016/j.ejca.2010.09.031

Zobrazit plný text záznamu

Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men

Autor: Hartwig Huland, Patrik Finne, Mark F. Wildhagen, Bob Djavan, Carsten Stephan, Bert G. Blijenberg, Markus Graefen, Axel Semjonow, Chuanliang Xu, Hellmuth-Alexander Meyer, Alexander Haese, Henning Cammann, Klaus Jung, Eleftherios P. Diamandis, Ulf-Håkan Stenman, Mesut Remzi

Publikováno v: World Journal of Urology, 25(1), 95-103. Springer-Verlag

Use of percent free PSA (%fPSA) and artificial neural networks (ANNs) can eliminate unnecessary prostate biopsies. In a total of 4,480 patients from five centers with PSA concentrations in the range of 2-10 ng/ml an IMMULITE PSA-based ANN (iANN) was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dcc941135f39d2aa0c5d281b60afec6
https://doi.org/10.1007/s00345-006-0132-9

Zobrazit plný text záznamu

Additional use of [−2] precursor prostate-specific antigen and 'benign' PSA at diagnosis in screen-detected prostate cancer

Autor: Harry G. Rittenhouse, Bert G. Blijenberg, Stephan D. Mikolajczyk, Fritz H. Schröder, René Raaijmakers, Stijn H. de Vries

Publikováno v: Urology, 65, 926-930. Elsevier Inc.

Objectives To evaluate the adjuvant clinical use of [−2] precursor prostate-specific antigen ([−2]pPSA), which is associated with prostate cancer (PCa), and “benign” PSA, related to benign prostatic hyperplasia, in selecting a treatment strat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e447a63f841382ae990d9d5f7cb90c2
https://doi.org/10.1016/j.urology.2004.11.030

Zobrazit plný text záznamu

PROSTATE CANCER DETECTION IN THE PROSTATE SPECIFIC ANTIGEN RANGE OF 2.0 TO 3.9 NG/ML: VALUE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN ON TUMOR DETECTION AND TUMOR AGGRESSIVENESS

Autor: Fritz H. Schröder, Bert G. Blijenberg, Judith A. Finlay, René Raaijmakers, Monique J. Roobol, Mark F. Wildhagen, Harry G. Rittenhouse

Publikováno v: Journal of Urology, 171, 2245-2249. Elsevier Inc.

Purpose: We evaluated the positive predictive value and cancer detection rate in the prostate specific antigen (PSA) range of 2.0 to 3.9 ng/ml and assessed the value of percent free (F) PSA (FPSA) on tumor detection and tumor aggressiveness in this l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b6171038fd4bbf41a058cab0f0e7035
https://doi.org/10.1097/01.ju.0000127731.56103.50

Zobrazit plný text záznamu

The value of (−7, −5)pro-prostate-specific antigen and human kallikrein-2 as serum markers for grading prostate cancer

Autor: Bert G. Blijenberg, Chris H. Bangma, Fritz H. Schröder, G. Yurdakul, Mark F. Wildhagen

Publikováno v: BJU International, 93, 720-724. Wiley-Blackwell Publishing Ltd

OBJECTIVE To assess the value of the precursor form (-7,5pro) of prostate-specific antigen (PSA) and human kallikrein-2 (hK2) for detecting and grading prostate cancer, as better serum markers with improved specificity are needed in men with lower ra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d5130deff401c81ad2d00eb16edffb
https://doi.org/10.1111/j.1464-410x.2003.04733.x

Zobrazit plný text záznamu

Prostate cancer characteristics and prostate specific antigen changes in screening detected patients initially treated with a watchful waiting policy

Autor: Fritz H. Schröder, René Raaijmakers, Bert G. Blijenberg, Ries Kranse, Stijn H. de Vries

Publikováno v: Journal of Urology, 172, 2193-2196. Elsevier Inc.

We evaluated prostate cancer (PCa) characteristics at diagnosis and changes in prostatic specific antigen (PSA) with time in males with screening detected PCa that was initially managed with a watchful waiting policy.Patients with histologically prov

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54889e5e6a38e6506ef4ac2ffaeebaec
https://doi.org/10.1097/01.ju.0000140958.31366.9f

Zobrazit plný text záznamu

Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening with a

Autor: R.H.N. van Schaik, Bert G. Blijenberg, Kazuto Ito, Fritz H. Schröder, Monique J. Roobol, Joseph A M J L Janssen, S. W. J. Lamberts, H. A. P. Pols, Mark F. Wildhagen

Publikováno v: Journal of Clinical Endocrinology and Metabolism, 89(9), 4391-4396. Endocrine Society

Recent studies have reported that serum IGF-I levels in the highest quartile of the normal range and IGF binding protein-3 (IGFBP-3) in the lowest quartile of the normal range are associated with an increased risk of future prostate cancer and/or pre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3338ef81c9f8e9b516b6249022db100f
https://doi.org/10.1210/jc.2004-0232

Zobrazit plný text záznamu

Different PSA Assays Lead to Detection of Prostate Cancers with Identical Histological Features

Autor: C.H. Bangma, G. Yurdakul, Th.H. van der Kwast, F.H. Schröder, B.D. Van Zelst, Mark F. Wildhagen, Bert G. Blijenberg

Publikováno v: European Urology, 42, 154-158. Elsevier

Objective: Because different PSA assays still show a wide inter-assay variation, we wondered what influence these discrepancies could have on the individual tumour characteristics of the cancers that each of these assays detect in a critical low PSA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0a09a380c62cea334d690589f06d82f
https://doi.org/10.1016/s0302-2838(02)00278-6

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání